indazoles has been researched along with Recrudescence in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 16 (76.19) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatla, N; Khurana, S; Kumar, L; Kumar, S; Malik, PS; Ray, MD; Sharma, A | 1 |
| Aster, JC; Craig, JW; Dail, M; Downing, JR; Hasserjian, RP; Hayes, K; Huang, BJ; Jonsson, P; Kogan, SC; Li, Q; Meyer, LK; Monsalve, G; Nakitandwe, J; Sampath, D; Scacchetti, A; Shannon, K; Taylor, BS; Wandler, AM; Weinberg, O; Wong, JC; Yamamoto, K; Yan, H; Zhang, J | 1 |
| Bitler, BG; Bradford, AP; Corr, BR; Moroney, MR; Qamar, L; Wolsky, R; Woodruff, E | 1 |
| Assouline, S; Awan, FT; Hill, B; Patel-Donnelly, D; Rao, AV; Sharman, JP; Thirman, MJ; Ye, W | 1 |
| Berdel, WE; Bormann, E; Brümmendorf, TH; Crysandt, M; Gerss, J; Hartmann, W; Kessler, T; Kirsch, A; Koschmieder, S; Lenz, G; Mikesch, JH; Müller-Tidow, C; Pohlen, M; Schliemann, C; Stelljes, M; Vehring, K; von Stillfried, S; Wardelmann, E | 1 |
| Liang, H | 1 |
| Bennouna, J; Botbyl, J; de Labareyre, C; Delord, JP; Deslandres, M; Ruiz-Soto, R; Senellart, H; Suttle, AB; Wixon, C | 1 |
| Chernova, M; Gao, L; Jia, W; Mihm, MC; Nadora, DM; Nelson, JS; Phan, S; Preciado, SM; Sun, V; Tan, W; Wang, G | 1 |
| Aspinall, A; Bathe, OF; Burak, KW; Chen, E; Dhani, N; Horgan, AM; Kim, TK; Knox, JJ; Le, LW; Lo, G; McNamara, MG; Rogalla, P; Sinaei, M | 1 |
| Akihama, S; Habuchi, T; Inoue, T; Koizumi, A; Narita, S; Numakura, K; Saito, M; Satoh, S; Takahashi, M; Takayama, K; Tsuchiya, N; Tsuruta, H | 1 |
| Greenberg, A; Matta, SK; Singh, A | 1 |
| Chuman, H; Hayashi, Y; Iwase, H; Kawai, A; Kobayashi, E; Makino, Y; Nakatani, F; Sano, T; Tanzawa, Y | 1 |
| Basso, E; Bergamaschi, L; Carta, R; Casanova, M; Chiaravalli, S; Fagioli, F; Ferrari, A; Magni, C; Massimino, M; Tirtei, E | 1 |
| Amaya-Guio, J; Grillo-Ardila, CF; Martinez-Velasquez, MY; Sierra-Barrios, EM; Viveros-Carreño, DA | 1 |
| Kishikawa, H; Nakagawa, M; Nakazawa, S; Nishimura, K; Sekii, Y; Yoshinaga, M | 1 |
| Alber, JA; Ding, J; Mas Lopez, L; Monk, BJ; Oaknin, A; Pandite, LN; Stutts, MW; Tarpin, C; Termrungruanglert, W; Zarba, JJ | 1 |
| Albert, DH; Carlson, DM; Dudley, M; Enschede, S; Glaser, K; Hogge, D; Koh, LP; Li, X; McKeegan, E; Pradhan, R; Stock, W; Wang, ES; Yee, K | 1 |
| Barriuso, J; Curtis, CM; Dar, MM; de Bono, J; Groves, MD; Ma, B; McLendon, RE; Mikkelsen, T; Nabors, L; Raizer, J; Reardon, DA; Rosenfeld, S; Suttle, AB; Wen, PY | 1 |
| Brand, L; Harvey, BH; Oosthuizen, F; Stein, DJ; Wegener, G | 1 |
| Chapman, GB; Durante, W; Evans, AJ; Peyton, KJ; Schafer, AI; Tulis, DA | 1 |
| Li, SM; Ren, YH; Zheng, JW | 1 |
2 review(s) available for indazoles and Recrudescence
| Article | Year |
|---|---|
Antibiotic treatment for the sexual partners of women with bacterial vaginosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Clindamycin; Female; Humans; Indazoles; Lincosamides; Male; Metronidazole; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Sexual Partners; Time Factors; Tinidazole; Vaginosis, Bacterial | 2016 |
[Recurrence of Well Differentiated Intrascrotal Liposarcoma in Retroperitoneum Five Years after Resection : A Case Report].
Topics: Aged; Angiogenesis Inhibitors; Chemotherapy, Adjuvant; Humans; Indazoles; Liposarcoma; Male; Orchiectomy; Pyrimidines; Recurrence; Retroperitoneal Neoplasms; Sulfonamides; Testicular Neoplasms; Time Factors; Tomography, X-Ray Computed | 2017 |
7 trial(s) available for indazoles and Recrudescence
| Article | Year |
|---|---|
Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Humans; Indazoles; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors; Pyrazines; Receptors, Antigen, B-Cell; Recurrence; Retreatment; Treatment Outcome | 2019 |
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML).
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Marrow; Female; Gastrointestinal Diseases; Humans; Indazoles; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Microvessels; Middle Aged; Progression-Free Survival; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Salvage Therapy; Sulfonamides; Treatment Outcome; Tumor Microenvironment | 2019 |
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cetuximab; Colorectal Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Indazoles; Irinotecan; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Protein Kinase Inhibitors; Pyrimidines; Recurrence; Sulfonamides; Topoisomerase I Inhibitors; Treatment Outcome | 2015 |
A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma.
Topics: Adult; Aged; alpha-Fetoproteins; Angiogenesis Inhibitors; Antineoplastic Agents; Axitinib; Biomarkers, Tumor; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Imidazoles; Indazoles; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Patient Selection; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Recurrence; Treatment Outcome; Vascular Endothelial Growth Factor A | 2015 |
Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Delivery Systems; Female; Humans; Indazoles; Lapatinib; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Recurrence; Retreatment; Sulfonamides; Uterine Cervical Neoplasms | 2010 |
Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; fms-Like Tyrosine Kinase 3; Humans; Indazoles; Leukemia, Myeloid, Acute; Male; Middle Aged; Phenylurea Compounds; Recurrence; Treatment Outcome | 2012 |
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.
Topics: Adult; Angiogenesis Inhibitors; Anticonvulsants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease-Free Survival; Drug Delivery Systems; ErbB Receptors; Glioma; Humans; Indazoles; Lapatinib; Neoplasm Recurrence, Local; Neoplasm Staging; Pyrimidines; Quinazolines; Recurrence; Sulfonamides | 2013 |
12 other study(ies) available for indazoles and Recrudescence
| Article | Year |
|---|---|
Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis.
Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Celecoxib; Cyclophosphamide; Drug Therapy; Etoposide; Female; Humans; Indazoles; India; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Pyrimidines; Recurrence; Sulfonamides | 2019 |
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia.
Topics: Animals; Dexamethasone; Drug Resistance, Neoplasm; Humans; Indazoles; Male; Mice; Mice, Inbred C57BL; Mutation; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Glucocorticoid; Recurrence; Sulfonamides | 2020 |
Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
Topics: beta Catenin; Cell Line, Tumor; Cell Survival; Disease Management; Disease Susceptibility; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Indazoles; Molecular Targeted Therapy; Mutation; Pyridines; Recurrence; Wnt Proteins; Wnt Signaling Pathway | 2021 |
[Treatment strategy for recurrent and metastatic gastrointestinal stromal tumors].
Topics: Benzamides; Disease-Free Survival; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indazoles; Indoles; Liver Neoplasms; Phenylurea Compounds; Piperazines; Pyridines; Pyrimidines; Pyrroles; Recurrence; Sulfonamides; Sunitinib | 2014 |
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser.
Topics: Administration, Cutaneous; Angiogenesis Inhibitors; Animals; Axitinib; Combined Modality Therapy; Extracellular Signal-Regulated MAP Kinases; Imidazoles; Indazoles; Lasers, Dye; Male; MAP Kinase Signaling System; Neovascularization, Pathologic; Port-Wine Stain; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Recurrence; Ribosomal Protein S6 Kinases; RNA, Messenger | 2015 |
[Pazopanib for three patients with recurrence of retroperitoneal liposarcoma : initial clinical experience].
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Humans; Indazoles; Liposarcoma; Male; Middle Aged; Neoplasm Staging; Pyrimidines; Recurrence; Retroperitoneal Neoplasms; Sulfonamides; Tomography, X-Ray Computed | 2015 |
Diarrhea With Clostridium difficile-Positive Stool-Trick or Treat: A Teachable Moment.
Topics: Aged; Anti-Bacterial Agents; Axitinib; Carcinoma, Renal Cell; Clostridioides difficile; Costs and Cost Analysis; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Imidazoles; Indazoles; Metronidazole; Protein Kinase Inhibitors; Recurrence; Treatment Outcome; Vancomycin; Withholding Treatment | 2015 |
[A Case of Severe Hematological Toxicity in Response to Pazopanib].
Topics: Angiogenesis Inducing Agents; Female; Humans; Indazoles; Leiomyosarcoma; Middle Aged; Neutropenia; Pyrimidines; Recurrence; Retroperitoneal Neoplasms; Sulfonamides; Thrombocytopenia | 2016 |
Response to pazopanib in two pediatric patients with pretreated relapsing synovial sarcoma.
Topics: Adolescent; Angiogenesis Inhibitors; Female; Humans; Indazoles; Male; Pyrimidines; Recurrence; Sarcoma, Synovial; Sulfonamides | 2017 |
Stress-restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus.
Topics: Animals; Chromatography, High Pressure Liquid; Corticosterone; Electrochemistry; Enzyme Inhibitors; gamma-Aminobutyric Acid; Guanidines; Hippocampus; Indazoles; Ketoconazole; Kinetics; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recurrence; Stress Disorders, Post-Traumatic; Stress, Psychological | 2004 |
YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation.
Topics: Angioplasty, Balloon; Animals; Carotid Arteries; Carotid Artery Injuries; Carotid Stenosis; Cyclic GMP; Gene Expression Regulation, Enzymologic; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Indazoles; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Recurrence; RNA, Messenger; Transcription, Genetic; Tunica Intima | 2000 |
Effect of 7-nitroindazole on drug-priming reinstatement of D-methamphetamine-induced conditioned place preference.
Topics: Amphetamine-Related Disorders; Animals; Conditioning, Psychological; Homing Behavior; Indazoles; Male; Methamphetamine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Recurrence; Stereoisomerism | 2002 |